GMAB News and Press, Genmab A/S From 07/27/21

Biotech companies have experienced exponential growth over the past year owing to their contribution to efforts to combat the COVID-19 pandemic. The rising demand for medicines and therapies for treating several other critical diseases and significant breakthroughs in developing customized dr...

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA And Healthcare Dashboard For July

Should Penny Stocks Be On Your List In 2021? Cancer stocks are some of the most popular among investors. Yes, we’re talking about companies in an industry working to tackle the second largest cause of death worldwide after cardiovascular disease. But we’re also talking...

Michael Vi/iStock Editorial via Getty Images Johnson & Johnson's (JNJ) Janssen division received two European Commission ("EC") marketing authorizations for Darzalex SC, a subcutaneous formulation of Darzalex (daratumumab). The first is for Darzalex SC in combination with Velcade (bo...

Looking For Stocks Moving Today? Here Are 4 Biotech Stocks To Check Out. Biotech stocks have been piquing the interest of many investors in the stock market lately. Well, this is largely due to the progress that we have seen in the treatment of Alzheimer’s disease shown b...

Collaboration to discover and evaluate novel product concepts based on the combination of Genmab’s antibodies and bispecific antibody technologies with Bolt’s proprietary immune-stimulating antibody conjugate (ISAC) platform Companies intend to develop multiple...

Genmab (GMAB) announces today that EMA's Committee for Medicinal Products for Human Use ((CHMP)) has adopted a positive opinion and recommended granting marketing authorization for Darzalex SC, in combination with bortezomib, cyclophosphamide, and dexamethasone for the treatment of adult pati...

Image source: The Motley Fool. Genmab A/S (NASDAQ: GMAB) Q1 2021 Earnings Call May 6, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Genmab A/S (GMAB) Q1 2021 Earnings Call Transcript

Genmab A/S (GMAB) Q1 2021 Earnings Conference Call May 05, 2021 12:00 PM ET Company Participants Jan van de Winkel - Co-Founder, President & Chief Executive Officer Anthony Pagano - Chief Financial Officer Conference Call Participants Wimal Kapadia - Bernstein Michael Schmidt - Guggenheim...

Genmab A/S (GMAB): Q1 GAAP EPS of DKK16.61.Revenue of DKK1.58B (+77.1% Y/Y)Press Release For further details see: Genmab A/S reports Q1 results